Unlocking youthful vitality: Discover the secrets of cycloastragenol
Are you longing for a way to rejuvenate from the root? Cycloastragenol, a natural saponin derived from the Astragalus plant, is becoming a rising star in the field of health and anti-aging with its unique biological properties.
Delaying aging
The most striking feature of cycloastragenol is its potential association with telomerase. Telomeres are the "protective caps" at the ends of chromosomes, which shorten as cells divide. When shortened to a certain extent, they may cause cell aging. Cycloastragenol is believed to delay the cell aging process by activating telomerase and helping to maintain telomere length [1]. Although human studies are still ongoing, this mechanism brings new hope for maintaining cell vitality.
Anti-inflammatory properties
In addition to its potential connection with telomerase, cycloastragenol is also believed to have significant immunomodulatory and anti-inflammatory properties. It may help the body better cope with inflammatory challenges and maintain the balance of the immune system by regulating the function of immune cells [2]. A study showed that cycloastragenol can significantly inhibit the production of pro-inflammatory cytokines and promote the release of anti-inflammatory cytokines, showing strong anti-inflammatory potential [3].
Cycloastragenol, as a crystallization of wisdom gifted by nature, is opening a new window for people who pursue a healthy and energetic life with its multiple potentials. Choosing cycloastragenol may mean choosing a more active and lasting youthful lifestyle.
References:
1.Chen, X., et al. (2011). Astragaloside IV and cycloastragenol activate telomerase activity via upregulating human telomerase reverse transcriptase transcription in vascular endothelial cells. Molecular Medicine Reports, 4(5), 923-928.
2.Chen, X., et al. (2011). Astragaloside IV and cycloastragenol activate telomerase activity via upregulating human telomerase reverse transcriptase transcription in vascular endothelial cells. Molecular Medicine Reports, 4(5), 923-928.
3.Li, N., et al. (2010). Astragaloside IV inhibits LPS-induced inflammatory responses by blocking NF-κB and MAPK pathways. Inflammation, 33(5), 317-326